RxSight, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
RxSight, Inc. (RXST) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.04 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-05
- RxSight, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 347.95K shares.
- RxSight, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was 12.40K shares.
- RxSight, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-03-31 was 787.10K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month |
|---|---|---|---|
| 2026-06-30 | 2.04M shares 10-Q · filed 2026-08-05 | ||
| 2024-09-30 | 347.95K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 360.35K shares derived: sum of 2 quarters · filed 2024-11-07 | 1.15M shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 12.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | 799.50K shares 10-Q · filed 2024-08-05 | |
| 2024-03-31 | 787.10K shares 10-Q · filed 2024-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |